FINNENCE ▪ THE WIRE FILE
THE WIRE · № 77571
News■ Mixed
NeuroSense Secures Nasdaq Hearing Date as PrimeC Approaches Key Regulatory and Funding Milestones
KINDNews
DIRECTION■ Mixed
SOURCES1
ENTITIES2
STORY SIZESTANDALONE
FIRST SEEN
LAST UPDATE
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
Nasdaq hearing and funding decision create binary near-term risk for a microcap biotech.
Microcap listing and funding catalysts pending
CATALYST TO WATCH
Health Canada submission in December 2026
MAIN RISK
Delisting if panel rules against
FULL DISPATCH
Shares continue to trade on Nasdaq pending the Panel's decision; minimum bid price compliance already regained Near-term catalysts include a New Drug Submission to Health Canada targeted for December 2026 and a decision on non-dilutive funding for the Phase 3 PARAGON trial expected in Q1...
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
SUBJECTNasdaq Composite · ^IXIC
AFFECTEDHealthcare
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares ^IXIC
Nasdaq notifies delisting of Vulcan Infrastructure & Power (VIP)'s 8.50% notes due 2026.2026-10-13 11:58 UTC
Nasdaq notifies delisting of Vulcan Infrastructure & Power (VIP)'s 8.50% notes due 2026.2026-10-13 11:58 UTC
→CORRELATIONshares Healthcare
The Argument For Biotech M&A To Reignite... And Soon2026-10-13 12:00 UTC
The Argument For Biotech M&A To Reignite... And Soon2026-10-13 12:00 UTC
→CORRELATIONshares Healthcare
Horizon Space Acquisition and ArcheNova Biotech announce merger2026-10-13 12:16 UTC
Horizon Space Acquisition and ArcheNova Biotech announce merger2026-10-13 12:16 UTC
→CORRELATIONshares Healthcare
Burnout, misinformation and financial vulnerability driving critical choices across American workforce, with Gen Z at the epicenter2026-10-13 13:03 UTC
Burnout, misinformation and financial vulnerability driving critical choices across American workforce, with Gen Z at the epicenter2026-10-13 13:03 UTC
→CORRELATIONshares Healthcare
CEO lists 6,938 shares for sale at MiNK Therapeutics (Nasdaq: INKT) following stock award vesting.2026-10-13 12:37 UTC
CEO lists 6,938 shares for sale at MiNK Therapeutics (Nasdaq: INKT) following stock award vesting.2026-10-13 12:37 UTC
→CORRELATIONshares Healthcare
Martin Shkreli violated lifetime pharma industry ban, FTC and states say in contempt claim2026-10-13 13:22 UTC
Martin Shkreli violated lifetime pharma industry ban, FTC and states say in contempt claim2026-10-13 13:22 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.